Stada and Xbrane receive approval for Ximluci
Biosimilar gains MHRA marketing authorisation for use throughout Britain - News - PharmaTimes
United Kingdom Bryan Kim United Kingdom Macular Society European Commission Ec Decision Reliance Procedure Regulatory Agency European Commission
Source: pharmatimes.com